EPO and chronic kidney disease: Modern medicine believes that the decreased secretion of erythropoietin (EPO) produced by the kidneys, insufficient raw materials such as iron and folic acid and the inhibition of bone marrow hematopoiesis are contributors to CKD with anemia [9, 10].